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Hypothalamic ribosomal S6K1 has been suggested
as a point of convergence for hormonal and nutrient
signals in the regulation of feeding behavior, body-
weight, and glucose metabolism. However, the
long-term effects of manipulating hypothalamic
S6K1 signaling on energy homeostasis and the
cellular mechanisms underlying these roles are un-
clear. We therefore inactivated S6K1 in pro-opiome-
lanocortin (POMC) and agouti-related protein (AgRP)
neurons, key regulators of energy homeostasis, but
in contrast to the current view, we found no evidence
that S6K1 regulates food intake and bodyweight. In
contrast, S6K1 signaling in POMC neurons regulated
hepatic glucose production and peripheral lipid
metabolism and modulated neuronal excitability.
S6K1 signaling in AgRP neurons regulated skeletal
muscle insulin sensitivity and was required for
glucose sensing by these neurons. Our findings sug-
gest that S6K1 signaling is not a general integrator of
energy homeostasis in the mediobasal hypothala-
mus but has distinct roles in the regulation of glucose
homeostasis by POMC and AgRP neurons.
INTRODUCTION
Obesity and its associated diseases such as type 2 diabetes and
cancer are major causes of morbidity and premature mortality
(Kopelman, 2000). The CNS orchestrates food intake, nutrient
storage, energy expenditure, and related behaviors (Morton
et al., 2014; Williams and Elmquist, 2012). Key neuronal popula-
tions have been identified that respond to both hormonal andnutrient signals that encode information about the internal meta-
bolic milieu and environmental factors such as diet and stress
(Williams and Elmquist, 2012). For example, anorexigenic pro-
opiomelanocortin (POMC) and orexigenic agouti-related peptide
(AgRP)-expressing neurons in the hypothalamic arcuate nucleus
coordinately regulate food intake and energy expenditure as well
as peripheral tissue glucose homeostasis and energy partition-
ing (Varela and Horvath, 2012).
A significant body of work has focused on identification of
common intracellular signaling pathways that respond to a range
of metabolic signals and may couple hormone and nutrient
sensing by neurons to the regulation of organismal metabolism.
One such pathway is the mechanistic target of rapamycin
(mTOR) signaling network (Andre´ and Cota, 2012; Blouet and
Schwartz, 2010; Haissaguerre et al., 2014). mTOR exists in two
distinct multimolecular complexes, mTORC1 and mTORC2,
which are thought to subserve distinct cellular roles (Laplante
and Sabatini, 2012). mTORC1 is responsive to a range of factors,
including growth factors, amino acids, energy status, and oxy-
gen and has been implicated in the regulation of protein synthe-
sis, lipogenesis, nucleic acid synthesis, and other processes
(Laplante and Sabatini, 2012). mTORC1 regulates, through
phosphorylation, a number of downstream effector proteins,
the best characterized of which are p70 ribosomal S6 protein
kinase-1 (S6K1) and eukaryotic translation initiation factor-4E
(eIF4E)-binding protein-1 (4E-BP1) (Laplante and Sabatini,
2012). S6K1 has been implicated in ribosomal biogenesis and
translational regulation as well as the control of cell size, gene
transcription, and the feedback regulation of insulin signaling
(Magnuson et al., 2012).
Hypothalamic mTORC1 signaling and S6K1 in particular have
been linked to the regulation of energy homeostasis (Blouet and
Schwartz, 2010; Haissaguerre et al., 2014). S6K1 is expressed in
the hypothalamus, including in POMC and AgRP neurons where
it is sensitive to nutrient status (Cota et al., 2006). HormonalCell Reports 11, 335–343, April 21, 2015 ª2015 The Authors 335
regulators of feeding behavior and bodyweight such as leptin, in-
sulin, and ghrelin modulate hypothalamic S6K1 signaling (Zhang
et al., 2011). Pharmacological inhibition of mTORC1 in the hypo-
thalamus using rapamycin blocks the anorectic effect of leptin,
leucine, and ghrelin (Cota et al., 2006; Martins et al., 2012), and
mice globally lacking S6K1 are resistant to the anorectic effects
of leptin (Cota et al., 2008). Adenovirally mediated acute overex-
pression of a constitutively active S6K1 in the mediobasal
hypothalamus (MBH) of rats suppresses food intake, lowers
weight gain, and improves insulin sensitivity (Blouet et al.,
2008), while dominant-negative S6K1 increases food intake
and weight gain, suggesting bidirectional regulation of energy
homeostasis by S6K1 (Blouet et al., 2008). Mediobasal hypotha-
lamic S6K1 may regulate peripheral glucose metabolism
although, in contrast to the findings described above, constitu-
tive activation of S6K1 results in hepatic insulin resistance
(Ono et al., 2008). These observations suggest that mTORC1
and S6K1 in particular may play a key integrative role in hypotha-
lamic nutrient and hormonal sensing and the regulation of energy
homeostasis.
Despite these findings, a number of issues remain unclear with
respect to the role of S6K1 in the hypothalamus. For example,
the use of acute non-targeted viral systems to manipulate
S6K1 signaling has not permitted long-term studies on energy
balance and glucose homeostasis or revealed any specific
contribution of POMC and AgRP neurons. The effects of hypo-
thalamic S6K1 on peripheral glucose metabolism also require
clarification (Blouet et al., 2008; Ono et al., 2008). Finally, there
is little information on how altered hypothalamic S6K1 signaling
might mechanistically regulate neuronal function and energy
homeostasis. We therefore generated mice lacking S6K1
(Rps6kb1) specifically in either POMC or AgRP neurons. In
contrast to published studies, we found a minimal role for
S6K1 in the long-term regulation of food intake and bodyweight.
S6K1 in POMC and AgRP neurons, however, played a key role in
neuronal excitability and the regulation of peripheral glucose
homeostasis.
RESULTS
Mice with Deletion of S6K1 in POMC and AgRP Neurons
Micewere generated on aC57Bl/6 backgroundwith exons 3 and
4 of Rps6kb1 flanked by loxP sites (Figure 1A). When bred to ho-
mozygosity, Rps6kb1 floxed (S6K1fl/fl) mice were phenotypically
indistinguishable from WT animals and displayed normal
Rps6kb1 expression in the absence of cre-recombinase (data
not shown). In mice with either germ-line deletion or with global
neuronal deletion (using either nestin-cre or synapsin-cre trans-
genic mice), western blotting confirmed complete loss of S6K1
in all tissues or specifically in the CNS, respectively (Figure 1B;
data not shown). Phosphorylated S6 was significantly reduced
in whole-brain lysates from nestin-cre S6K1fl/fl mice (Figure 1C).
S6K1fl/fl mice were subsequently bred with mice expressing cre-
recombinase driven by Pomc or Agrp promoters (POMCS6K1 or
AgRPS6K1, respectively), and the recombination event was
restricted to the hypothalamus in both knockout (KO) lines (Fig-
ures 1D and 1E). S6K1 immunoreactivity was co-localized with
WT fluorescently labeled POMC and AgRP arcuate neurons,336 Cell Reports 11, 335–343, April 21, 2015 ª2015 The Authorsbut expression was absent in Rps6kb1-deleted neurons (Figures
1F and 1G). POMC cre-recombinase mice also drive deletion in
pituitary corticotrophs, but corticosterone levels were equivalent
between WT and POMCS6K1-KO mice (WT, 41.3 ± 7.7 versus
KO, 45.3 ± 7.7 ng/ml, n = 4–6).
Assessment of Feeding and Bodyweight Phenotypes in
POMCS6K1KO and AgRPS6K1KO Mice
Food intake, ad libitum and in response to a fast, was unaltered
in POMCS6K1KO and AgRPS6K1KOmice on chow (Figures 2A–
2D), and average meal size, meal number, or feeding pattern
over a 24-hr period were not different (Figures S1A–S1D). Both
mutant lines responded normally to leptin and AgRPS6K1KO
mice displayed an unaltered response to ghrelin (Figures S1E–
S1G). Central neuropeptide Y (NPY, 1 mg) evoked rapid feeding,
but administration of leucine (2.2 mg) to the same animals did not
suppress feeding in both WT and POMCS6K1KO mice (Figures
S1H and S1I). POMCS6K1KO and AgRPS6K1KO mice re-
sponded normally to the effects of the melanocortin agonist
MTII (Figures S1J and S1K). As decreased melanocortin recep-
tor signaling can enhance adiposity in the absence of hyperpha-
gia (Nogueiras et al., 2007), we examined long-term bodyweight
regulation on chow and high-fat diet (HFD). Up to 34 weeks
of age, there were no differences in bodyweight, fat mass,
and serum leptin concentrations between POMCS6K1KO or
AgRPS6K1KO mice and their respective controls in either
gender (Figures 2E–2H, S1L, and S1M; data not shown).
POMCS6K1KOmice had amodest increase in fasted serum lep-
tin levels on a HFD at 34 weeks of age despite their normal
adiposity (Figure S1L). Light- or dark-phase energy expenditure,
respiratory exchange ratio, and locomotion were unchanged be-
tween chow-fed WT and POMCS6K1KO or AgRPS6K1KO mice
(Table S1). These data suggest that ablation of Rps6kb1
signaling in POMC and AgRP neurons does not affect food
intake or long-term bodyweight regulation.
Glucose Homeostasis in POMCS6K1 and
AgRPS6K1 Mice
As POMC and AgRP neurons regulate peripheral glucose ho-
meostasis, we studied this in POMCS6K1KO or AgRPS6K1KO
mice on chow and HFD. Fed or fasted serum glucose levels,
fasted insulin levels (Table S2), and glucose tolerance were not
different between control and mutant mice regardless of age
(8 and 26 weeks) or diet (data not shown), while POMCS6K1KO
mice had a mild impairment in insulin sensitivity on chow
(area under the curve: WT, 79.5 ± 2.0 versus KO, 86.7 ± 3.1,
n = 20–22, p < 0.05).
Hyperinsulinemic-euglycemic clamp studies were conducted
to reveal any potential tissue-specific regulation of glucose ho-
meostasis. Serum glucose concentrations, glucose infusion
rate (GIR), and insulin concentrations before and at the end
of the clamp were equivalent between male WT and
POMCS6K1KO or AgRPS6K1KO mice (data not shown). Under
basal conditions, whole-body glucose utilization, equivalent to
endogenous hepatic glucose production (HGP), did not differ be-
tweenWT and POMCS6K1KO or AgRPS6K1KOmice (Figures 2I
and 2J). During the hyperinsulinemic clamp, suppression of HGP
was impaired in POMCS6K1KO mice compared with controls
Figure 1. Generation of Conditional Rps6kb1 Floxed Mice
(A) Schematic diagram of the targeting approach for Rps6kb1 before and after homologous recombination into the mouse genomic locus. The neomycin (Neo)
resistance gene was removed by breeding with Flpe mice.
(B) Representative western blot analysis of S6K1 from brain lysates of nestin-cre S6K1fl/fl WT and KO mice.
(C) Western blots of phosphorylated S6 (pS6, top) and total S6 (bottom) in brain lysates from nestin-cre S6K1fl/fl WT and KO mice. Bar chart of the ratio between
pS6 and total S6 is show on the right. n = 4–5 mice per genotype, mean ± SEM, *p < 0.05.
(D and E) Representative PCR analysis for the floxed allele (top) and recombination (deletion) event (bottom) in POMCS6K1KO (D) and AgRPS6K1KO (E) mice.
M, skeletal muscle; L, liver; C, cerebral cortex; H, hypothalamus.
(F and G) Fluorescent (green) arcuate POMC (F) and AgRP (G) neurons inWT (left two panels) and KO (right two panels) mice are shown adjacently at low and high
magnifications. Representative S6K1 labeled neurons (red) co-localize with POMC and AgRP neurons inWT but notRps6kb1-deleted cells. Scale bars represent
50 and 10 mm for low- and high-magnification images, respectively.
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Figure 2. POMC and AgRP S6K1 Regulate
Peripheral Glucose Homeostasis but Not
Feeding Behavior and Bodyweight
(A and B) Ad libitum food intake in male WT (red
bars) and KO (blue bars) POMCS6K1 (A) and
AgRPS6K1 (B) mice on normal chow. POMCS6K1,
n = 20–23, and AgRPS6K1, n = 7–10 mice per
genotype. Mean ± SEM.
(C and D) Cumulative food intake from WT (red)
and KO (blue) male POMCS6K1 (C) and
AgRPS6K1 (D) mice following an overnight fast.
POMCS6K1, n = 20–23, and AgRPS6K1, n = 7–10,
mice per genotype. Mean ± SEM.
(E and F) Bodyweight curves for male POMCS6K1
(E) and AgRPS6K1 (F) mutant mice on normal
chow (n = 18–22 and n = 23–33mice per genotype,
respectively) or on a HFD (n = 19–21 and n = 19–26
mice per genotype, respectively). WT mice are
shown by red circles on chow and black circles on
HFD, whereas KO mice on chow or HFD are
shown in blue or green circles, respectively.
Mean ± SEM.
(G and H) EchoMRI analysis of WT (red) and KO
(blue) mice shown in (E) and (F). Fat and lean mass
at 34 weeks old in POMCS6K1 (G) and AgRPS6K1
(H) mice on normal chow (left) or HFD (right).
Mean ± SEM.
(I and J) Glucose disposal (Rd), GIR and HGP
during basal and hyperinsulinemic-euglycemic
clamp conditions from WT (red) and KO (blue)
POMCS6K1 (I) and AgRPS6K1 (J) mice. n = 8–9
mice per genotype, mean ± SEM, *p < 0.05.
(K and L) Skeletal muscle and white adipose tissue
(WAT) uptake of 14C-2-deoxyglucose-phosphate
(2-DG-P) fromWT (red) and KO (blue) POMCS6K1
(K) and AgRPS6K1 (L) mice shown in (I) and (J).
Mean ± SEM, **p < 0.001.
(M) Serum FFA concentration before and the
during hyperinsulinemic-euglycemic clamp in WT
(red) and KO (blue) POMCS6K1 mice shown in (I).
Mean ± SEM, **p < 0.001.
(N) Percentage reduction of serum FFA concen-
tration following hyperinsulinemic-euglycemic
clamp in WT (red) and KO (blue) POMCS6K1 mice
shown in (I). Mean ± SEM, *p < 0.05.(Figure 2I). In contrast, in AgRPS6K1KO mice, whole-body
glucose utilization during the clamp was reduced when
compared with controls (Figure 2J). While there were no differ-
ences in glucose uptake between WT and POMCS6K1KO
mice (Figure 2K), glucose uptake into skeletal muscle was
impaired in AgRPS6K1KO mice (Figure 2L).338 Cell Reports 11, 335–343, April 21, 2015 ª2015 The AuthorsIn POMCS6K1KO compared with con-
trol mice, fasted plasma free fatty
acid (FFA) levels were lower but not
suppressed by the hyperinsulinemic
clamp (Figures 2M and 2N). FFA levels
were not different between WT and
AgRPS6K1KO mice under basal (WT,
0.87 ± 0.05 versus KO, 1.07 ±
0.05 mmol/l, n = 10–11) and clamp condi-
tions (WT, 0.40 ± 0.05 versus KO, 042 ±0.03 mmol/l, n = 8). Total triglyceride levels were unaltered in
both lines (POMC: WT, 107.7 ± 5.7 versus KO, 101.0 ± 5.5 mg/
dl, n = 13; AgRP: WT, 121.4 ± 15.3 versus KO, 124.5 ±
11.4 mg/dl, n = 8–10). Together these findings indicate that
loss of Rps6kb1 in POMC neurons impairs central regulation of
HGP and also impacts upon peripheral lipid metabolism, while
loss of Rps6kb1 in AgRP neurons impairs skeletal muscle insulin
sensitivity.
Mechanisms Underlying Metabolic Phenotypes in
POMCS6K1KO and AgRPS6K1KO Mice
The liver expression of phosphoenolpyruvate carboxykinase-1
(Pck1), glucose-6-phosphatase, and interleukin-6 (a cytokine
implicated in the control of HGP) were unaltered in either
POMCS6K1KO or AgRPS6K1KO mice (Figures S2A and S2B).
Consistent with our finding of reduced FFA levels in
POMCS6K1KOmice, we found that adipose tissue mRNA levels
of hormone-sensitive lipase-1 were reduced (Figure S2C),
whereas those of stearoyl-CoA desaturase-1, fatty-acid syn-
thase, diacylglycerol o-acyltransferase-2, fatty-acid binding
protein-4, perilipin-1, and Pck1 were unaltered in both
POMCS6K1KO and AgRPS6K1KO mice (Figures S2C and
S2D). To study connections between the melanocortin system
and peripheral metabolism, we examined sympathetic nervous
system function. Urinary norepinephrine and epinephrine
concentrations, core temperature, and brown adipose tissue
gene expression were unaltered in both POMCS6K1KO and
AgRPS6K1KO mice, suggesting no major alteration in sympa-
thetic function (Figures S2E–S2G; data not shown). Next we
examined potential hypothalamic mechanisms that might un-
derlie the changes in peripheral metabolism in POMCS6K1KO
and AgRPS6K1KO mice. Hypothalamic Agrp, Npy, Pomc,
carboxypeptidase E, and melanocortin-4 receptor mRNA
expression was unaltered in POMCS6K1KO and AgRPS6K1KO
mice (Figures S2H and S2I). Phosphorylation of signal trans-
ducer and activator of transcription-3 (pSTAT3), a major medi-
ator of leptin action, was equivalent between WT and
POMCS6K1KO mice (Figures S3A–S3C). S6K1 has also been
reported to phosphorylate AMP-dependent protein kinase
(AMPK) on serine 485/491 to mediate leptin’s effect on food
intake (Dagon et al., 2012). However, we found no differences
in hypothalamic AMPK serine 485 phosphorylation after leptin
treatment in WT and mice lacking Rps6kb1 in all neurons
(Figure S3D).
In electrophysiology studies, leptin depolarized a sub-pop-
ulation of WT (9 of 16) and Rps6kb1-deleted (8 of 15) POMC
neurons (Figures S3E, S3F, and S3J). Similar to our previous
studies (Al-Qassab et al., 2009; Claret et al., 2007), insulin
modestly depolarized a subpopulation of WT (6 of 12 neu-
rons; Figures S3G and S3J) but also 4 of 12 Rps6kb1-
deleted AgRP neurons studied (Figure S3H). However, insulin
also hyperpolarized 2 of 12 Rps6kb1-deleted AgRP neurons;
thus, the population response to insulin as a whole showed
no significant change (Figures S3I and S3J). Although intra-
cerebroventricular (i.c.v.) leucine did not alter food intake,
leucine (5 mM) modestly depolarized WT POMC neurons,
but equivalent effects were seen in Rps6kb1-deleted cells
(DVm, WT, +3.0 ± 1.1 versus KO, +3.4 ± 1.0 mV, n = 5–6,
p < 0.05 from control; Figures S3K and S3L). These findings
suggest that S6K1 signaling in POMC neurons is not
required for the electrophysiological effects of leptin and
leucine and abrogation of S6K1 signaling in AgRP neurons
does not impact upon the electrophysiological effects of
insulin.Rps6kb1 Deletion Reduces Neuronal Excitability, Alters
AgRP Neuron Glucose Sensing and Synaptic Strength
and POMC Neuron Size
During these studies, it became evident that Rps6kb1-deleted
POMC and AgRP neurons were less excitable in 5 mM external
glucose (Figures 3A–3F), equivalent to fed glucose concentra-
tions in the brain (Routh, 2002). Rps6kb1-deleted POMC neu-
rons had a more hyperpolarized resting membrane potential
(Vm) and lower spike frequency than control POMC neurons
while input resistance was not different (Figures 3A, 3C, and
3E). Rps6kb1-deleted AgRP neurons also had a lower resting
spike firing frequency, but Vm and input resistance were equiv-
alent to control neurons (Figures 3B, 3D, and 3F). In separate re-
cordings, we examined the excitable properties of POMC and
AgRP neurons in 1 mM external glucose, which is similar to
fasted glucose concentrations measured in the brain (Routh,
2002). Control POMC neurons had a lower Vm and input resis-
tance when compared with recordings obtained in 5 mM
glucose, yet spike frequency was not different (Figures 3A, 3C,
and 3E). Input resistance in 1 mM glucose was also lower in
Rps6kb1-deleted POMC neurons when compared with record-
ings at the higher glucose concentration but resting Vm and
spike firing frequency were equivalent (Figures 3A, 3C, and
3E). In control AgRP neurons, lowering external glucose
decreased input resistance and spike frequency when
compared with recordings in 5 mM glucose, but Vm was not
significantly different (Figures 3B, 3D, and 3F). However, in
Rps6kb1-deleted AgRP neurons, Vm, spike frequency, and input
resistance were equivalent between the two external glucose
concentrations (Figures 3B, 3D, and 3F). Therefore, POMC neu-
rons lacking Rps6kb1 displayed a hyperpolarized resting mem-
brane potential in high glucose while the biophysical properties
of AgRP neurons lacking Rps6kb1 did not alter in different
glucose concentrations possibly indicating defective glucose
sensing. These defects may be due to altered ATP-sensitive K+
(KATP) channel subunit expression, and we found that Kcjn11
expression was significantly increased in POMCS6K1KO and
reduced in AgRPS6K1KO when compared with WT mice; how-
ever, Abcc9 expression was unchanged (Figures 3G and 3H).
Hypothalamic expression of glucokinase was reduced in
AgRPS6K1KO but unchanged in the POMCS6K1KO mice (Fig-
ures 3G and 3H).
Changes in synaptic weight in Rps6kb1-deleted AgRP neu-
rons could explain a lower firing frequency without an observable
difference in resting Vm. Therefore, we recorded from WT and
AgRPS6K1KO neurons and pharmacologically isolated minia-
ture excitatory (mEPSC) and inhibitory (mIPSC) post-synaptic
currents in the presence of tetrodotoxin (1 mM; Figures 4A–4H).
Mean mEPSC amplitude was slightly higher in Rps6kb1-deleted
AgRP neurons when compared with WT neurons (WT, 27.2 ±
0.2 versus KO,29.4 ± 0.2 pA, 4,243–4,505 events from 13 neu-
rons per genotype, p < 0.0001; Figures 4A and 4C). There were
no differences in decay time constants or event frequency (Fig-
ures 4E and 4G) between WT and KOs. In contrast, mIPSC
amplitude was significantly smaller in AgRPS6K1KO neurons
when compared with control cells (WT, 81.6 ± 2.1 versus
KO,49.0 ± 0.9 pA, 898–945 events from ten neurons per geno-
type, p < 0.0001; Figures 4B and 4D). Likewise, mIPSC decayCell Reports 11, 335–343, April 21, 2015 ª2015 The Authors 339
Figure 3. S6K1 Regulates the Excitable
Properties of POMC and AgRP Neurons
(A–F) Scatter plots of resting membrane potentials
(Vm, A and B), spike firing frequencies (C and D),
and input resistances (E and F) in POMC (A, C,
and E) and AgRP (B, D, and F) neurons in 5 mM
(POMC, n = 36–40 and AgRP, n = 17–28 neurons
per genotype) or 1 mM (POMC, n = 19–22 and
AgRP, n = 17 neurons per genotype) external
glucose, as indicated. Solid horizontal bars denote
median values. *p < 0.05, **p < 0.001. WT and KO
neurons are shown in red and blue circles,
respectively.
(G and H) Quantitative PCR for Kir6.2 (Kcjn11),
SUR1 (Abcc8) and glucokinase (Gck) from the
basomedial hypothalamus of fasted POMCS6K1
(G) and AgRPS6K1 (H) mice. n = 10–12 mice per
genotype. Mean ± SEM, *p < 0.05, **p < 0.001,
***p < 0.0001. WT and KO neurons are shown in
red and blue bars, respectively.constants were slower in Rps6kb1-deleted neurons when
compared with WT controls (WT, 9.9 ± 0.1 versus KO, 10.7 ±
0.2 ms, 898–945 events from ten neurons per genotype, p <
0.001; Figure 4F). Spontaneous mIPSC frequency was the
same between WT and Rps6kb1-deleted AgRP neurons (Fig-
ure 4H). Differences in the expression of GABAA receptor alpha
subunits may lead to alterations in kinetics, but we found no
changes in the expression of GABAA receptor alpha-subunits
1, 2, 3 and 5 in the hypothalamus of AgRPS6K1KO mice (Fig-340 Cell Reports 11, 335–343, April 21, 2015 ª2015 The Authorsure 4I). Together, these data show that
chronic deletion ofRps6kb1 in AgRP neu-
rons alters synaptic strength.
Next, we examined neuronal architec-
ture as S6K1 has been implicated in cell
growth. Initial indirect measurement of
cell size through cell capacitance mea-
surements did not identify a difference
between control and Rps6kb1-deleted
POMC and AgRP neurons (Figure S4A).
However, in immunohistochemistry
studies, somatic diameter and area was
approximately 5% smaller in Rps6kb1-
KO when compared with WT POMC neu-
rons (Figures S4B–S4D), while no overt
differences in POMC fibers in areas
such as the hypothalamic paraventricular
nucleus were observed (data not shown).
DISCUSSION
Hypothalamic S6K1 has been implicated
in the regulation of food intake, energy
expenditure, and bodyweight (Blouet
and Schwartz, 2010; Haissaguerre et al.,
2014). In contrast, in our studies specif-
ically ablating Rps6kb1 in POMC or
AgRP neurons, we find that this signaling
pathway does not play an indispensablerole in regulating these processes. We instead reveal a key role
for both POMC and AgRP neuronal S6K1 in peripheral glucose
metabolism and show that deletion of Rps6kb1 alters POMC
and AgRP neuron excitability and disrupts glucose sensing in
AgRP neurons. Potential explanations for the differences be-
tween our findings and previous work include the short-time win-
dow but high level of adenovirally mediated gene expression, the
lack of cell-selective manipulations, the presence of local hypo-
thalamic inflammation, acute post-operative weight loss, and
Figure 4. Synaptic Strength in AgRP Neu-
rons Is Altered by Rps6kb1 Deletion
(A and B) Representative overlapping (left) and
composite (right) miniature excitatory (A) and
inhibitory (B) post-synaptic currents (mEPSC
and mIPSC, respectively) in WT and Rps6kb1-
deleted (KO) AgRP neurons.
(C and D) Frequency histograms (left) and cumu-
lative frequency curves (right) are shown for
mEPSC (C) and mIPSC (D) amplitudes in WT (red)
and KO (blue) AgRP neurons. n = 10–13 neurons
per genotype.
(E and F) Normalized composite traces (left) with
cumulative frequency curves (right) for decay
times of mEPSC (E) and mIPSC (F) in WT (red) and
KO (blue) AgRP neurons. n = 10–13 neurons per
genotype.
(G and H) Bar charts of spontaneous mEPSC (G)
andmIPSC (H) event frequency inWT (red) and KO
(blue) AgRP neurons. n = 10–13 neurons per ge-
notype. Mean ± SEM.
(I) Quantitative PCR analysis for GABAA receptor
alpha subunits 1, 2, 3, and 5 (Gabra1, Gabra2,
Gabra3, Gabra5, respectively) in the MBH of fas-
ted WT (red) and KO (blue) AgRPS6K1 mice.
n = 10–12 mice per genotype. Mean ± SEM.anorexia complicating the interpretation of feeding and body-
weight data and potential off-target effects of the constructs.
Chronic deletion may also lead to compensatory changes such
as upregulation of S6K2, but in our preliminary studies deleting
both Rps6kb1 and Rps6kb2 in POMC neurons, we find no
changes in food intake or bodyweight (Figures S4E and S4F). It
is also conceivable that the effects of S6K1 on energy balanceCell Reports 11, 335–3are due to signaling in other MBH cell
populations. Yet, this is unlikely as
global neuronal deletion of Rps6kb1
achieved using nestin-cre mice did not
lead to alterations in bodyweight or insu-
lin tolerance (Figures S4G and S4H). In
contrast, our broad range of relevant
physiological, molecular, and electro-
physiological data indicate that S6K1 is
not required for the hypothalamic regula-
tion of food intake, bodyweight, and
energy expenditure.
Rapamycin blocks the anorexigenic
effects of leptin (Cota et al., 2006), but
the lack of effect of Rps6kb1-deletion on
acute leptin regulation of both food intake
and POMC neuron excitability and
signaling suggests the involvement of an
alternative rapamycin-sensitive mecha-
nism. S6K1 also phosphorylates AMPK
on serine 485/491, an event that inhibits
AMPK activity and is required for leptin’s
effect on food intake (Dagon et al., 2012).
However, we were unable to detect dif-
ferences in AMPK serine 485 phosphory-lation after leptin treatment between WT and mice lacking
Rps6kb1 in all neurons. Ghrelin action in AgRPS6K1KO mice
was also normal. S6K1 has also been suggested to mediate
the anorexigenic effects of central administration of leucine
(Blouet et al., 2009; Cota et al., 2008), and while we were unable
to detect a suppression of food intake, the persistence of leu-
cine’s electrophysiological actions in Rps6kb1-deficient POMC43, April 21, 2015 ª2015 The Authors 341
neurons suggest that S6K1 is not required for this component of
leucine’s actions.
We find that S6K1 signaling in POMC and AgRP neurons reg-
ulates glucose homeostasis. Previous studies have given con-
flicting results, with one suggesting that hypothalamic activation
of S6K1 signaling causes hepatic insulin resistance and its inhi-
bition improves hepatic insulin sensitivity (Blouet et al., 2008),
while another showed essentially the opposite findings (Ono
et al., 2008).We show that deletion ofRps6kb1 in POMCneurons
leads to defective regulation of HGP, while deletion in AgRP neu-
rons causes skeletal muscle insulin resistance. In POMC neu-
rons leptin receptor signaling alone, or in combination with
insulin receptor signaling, and phosphatidylinositol-3 kinase
signaling have both been shown to regulate HGP (Berglund
et al., 2012; Hill et al., 2010; Hill et al., 2008). Insulin-receptor
signaling in AgRP neurons likewise regulates HGP (Ko¨nner
et al., 2007). Melanocortin circuits control both HGP and insulin
sensitivity in skeletal muscle and adipose tissue function (Ber-
glund et al., 2014; Nogueiras et al., 2007; Obici et al., 2001; Rossi
et al., 2011). Our studies implicate S6K1 signaling in POMC neu-
rons as one of the mechanisms by which this cell type regulates
HGP and peripheral lipid metabolism. We also show a role for
AgRP neurons in regulating skeletal muscle sensitivity and impli-
cate S6K1 signaling in this process.
Hypothalamic neuronal excitability is modulated by external
glucose by inhibition of KATP channels following the uptake and
metabolism of glucose (Levin et al., 2004). Glucose sensing in
POMC neurons has been shown to regulate peripheral glucose
homeostasis (Parton et al., 2007), and reducing glucose to hypo-
glycemic conditions hyperpolarizes both POMC and AgRP neu-
rons (Claret et al., 2007). Consistent with the opening of a resting
conductance, input resistance in both POMC and AgRP
neuronal populations was lower in an external glucose concen-
tration (1 mM) reflecting the fasted state (Routh, 2002) in
comparison with recordings obtained in a higher glucose con-
centration (5 mM). However, low glucose did not alter the
biophysics of AgRPS6K1KO neurons, which may indicate a
loss of glucose sensing in these cells, which could underpin
alterations in peripheral glucose metabolism. A reduction in the
expression of a pore-forming subunit of KATP channels and the
enzyme glucokinase, which initiates glucose metabolism may
contribute to this loss of glucose sensing. POMCS6K1KO neu-
rons had a lower input resistance when compared with record-
ings in higher glucose concentrations, suggesting that glucose
sensing is intact. However, these neurons had lower resting
membrane potential and spike firing frequency than control
POMC neurons, whichmay imply a reduction in basal transmitter
release, which could alter peripheral glucose homeostasis. The
properties and kinetics of voltage-dependent conductances or
the electrogenic properties of the neuron due to changes in anat-
omy may be modulated by S6K1 to alter resting excitability.
Although cell capacitance measurements in Rps6kb1-deficient
and control POMC neurons did not suggest alterations, in immu-
nohistochemical anatomical assessments, we found a very small
reduction in soma size. One caveat with electrophysiological re-
cordings of individual neurons is that this technique can only
capture small samples within the wider neuronal population. In
the case of POMC and AgRP neurons, which display some func-342 Cell Reports 11, 335–343, April 21, 2015 ª2015 The Authorstional heterogeneity and do not all respond to the same hor-
mones and nutrients, it is possible that some neurons that
have altered responses are undetected.
In summary, our studies define the physiological and cellular
roles of S6K1 signaling in POMC and AgRP neurons and give in-
sights into the role of this pathway in the CNS regulation of
energy homeostasis. We find no role for hypothalamic S6K1 in
the regulation of feeding and bodyweight but demonstrate a
key role for this molecule in glucose homeostasis.
EXPERIMENTAL PROCEDURES
Mice and Animal Care
The use and genotyping of POMCCre, AgRPCre (both on a C57Bl/6 back-
ground), and NestinCre (on a mixed C57Bl/6 3 129sv background) mice have
been previously described (Al-Qassab et al., 2009; Choudhury et al., 2005;
Claret et al., 2011). Mice with floxed alleles for Rps6kb1 on a C57Bl/6 back-
ground were generated by Taconic Biosciences and crossed with the Cre-ex-
pressing transgenic mice to generate compound heterozygotes. These mice
were intercrossed with Rps6kb1fl/wt mice to obtain WT (Cre//Rps6kb1wt/wt,
Cre//Rps6kb1fl/fl, Cre+//Rps6kb1wt/wt), and KO (Cre+//Rps6kb1fl/fl) mice
for each line. To generate mice lacking floxed alleles but expressing GFP or
YFP in cells harboring the deletion event, mice were bred with POMC-GFP or
Rosa26YFP indicator mice and bred to homozygosity for the floxed allele.
Mice were maintained on a 12-hr light/dark cycle with free access to water
and standard mouse chow (4.25% fat, RM3; Special Diet Services) or HFD
(45%fat, D12451;ResearchDiets) andhoused in specific-pathogen free barrier
facilities in individually ventilated cages of mixed genotypes. All KO and
transgenic mice were studied with appropriate littermates of the three control
genotypes. Mice were handled and all in vivo studies performed in accordance
to theUnitedKingdomAnimals (ScientificProcedures) Act (1986) and approved
by Imperial College’s Animal Welfare and Ethical Review Body.
Statistical Analysis
Data are expressed as mean ± SEM unless otherwise stated, and the single
animal was the unit of analysis unless otherwise stated. Statistical significance
was calculated at the 95% level of confidence using parametric (unpaired
and paired t tests, one-way ANOVA, repeated-measures two-way ANOVA)
or non-parametric (Kruskal-Wallis) tests with post hoc Bonferroni’s or Dunn’s
multiple comparison analysis, where appropriate. Statistical significance was
calculated from all electrophysiological recordings (responsive and non-
responsive).
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 Figure S1. S6K1 is not required for the regulation of food intake 
(A-D) Automated food intake monitoring of meal size (A and B, left), meal number (A and B, 
right) and cumulative food intake (C and D) for ad-libitum fed wild-type (WT, red bars/circles) 
and knockout (KO, blue bars/circles) male POMCS6K1 (A and C) and female AgRPS6K1 (B 
and D) mice. N=6-7 mice per genotype. Data presented is mean ± SEM.  
(E and F) Leptin-induced (i.p. 0.3 mg/kg twice daily) reduction in food intake (left) and 
bodyweight (right) over 3 days in male POMCS6K1 (E) and AgRPS6K1 (F) WT (red bar) and 
KO (blue bar) mice. POMC: N=17-21; AgRP: N=17-19 mice per genotype. Data presented is 
mean ± SEM.  
(G) Cumulative food intake for WT and KO AgRPS6K1 mice treated with vehicle (red and 
blue bars, respectively) or ghrelin (i.p. 5 mg/kg) (grey and white bars, respectively). N=10-12 
mice per genotype. Data presented is mean ± SEM. *P<0.05, **P<0.001, ****P<0.00001. 
(H) One hour food intake in WT and KO POMCS6K1 mice i.c.v. injected with vehicle (red 
and blue bars, respectively) or NPY (1 µg) (grey and white bars, respectively). N=3-8 mice 
per genotype or treatment. Data presented is mean ± SEM. **P<0.001, ****P<0.00001. 
(I) Cumulative food intake in overnight fasted WT and KO POMCS6K1 mice i.c.v. injected 
with vehicle (red and blue bars, respectively) or leucine (2.2 µg) (grey and white bars, 
respectively). N=9-12 mice per genotype. Data presented is mean ± SEM.  
(J and K) Cumulative food intake for WT and KO POMCS6K1 (J) and AgRPS6K1 (K) mice 
treated with vehicle (red and blue bars, respectively) or melanotan-II (MTII) (i.p. 2 mg/kg) 
(grey and white bars, respectively). N=9-12 and N=6 mice per genotype for POMCS6K1 and 
AgRPS6K1, respectively. Data presented is mean ± SEM. *P<0.05, **P<0.001, 
****P<0.00001. 
(L and M) Fasted serum leptin concentrations for WT (red bars) and KO (blue bars) mice 
shown in Figure 2 panels E and F. Data shown is from 34 week old POMCS6K1 (L) and 
AgRPS6K1 (M) mice fed on normal chow (left) or HFD (right) and shows mean ± SEM. 
*P<0.05.  
  
 Figure S2. Gene expression in peripheral and hypothalamic tissues and urinary 
catecholamine concentrations 
(A and B) Expression of mRNA for phosphoenolpyruvate carboxykinase-1 (Pck1), glucose-
6-phosphatase (G6pc) and interleukin-6 (IL6) in liver of fasted wild-type (WT, red bar) and 
knockout (KO, blue bar) POMCS6K1 (A) or AgRPS6K1 mice (B). N=6-12 mice per 
genotype. Data presented is mean ± SEM.  
(C and D) Expression of mRNA for stearoyl-CoA desaturase-1 (Scd1), fatty-acid synthase 
(Fasn), diacylglycerol o-acyltransferase 2 (Dgat2), Pck1, hormone-sensitive lipase-1 (Lipe), 
fatty-acid binding protein-4 (Fabp4) and perilipin-1 (Plin1) in white adipose tissue (WAT) of 
fasted WT (red bar) and KO (blue bar) POMCS6K1 (C) and AgRPS6K1 (D) mice. N=6-10 
mice per genotype. Data presented is mean ± SEM. *P<0.05. 
(E and F) Urinary concentrations of norepinephrine (left, N=7-13 mice per genotype) and 
epinephrine (right, N=4-7 mice per genotype) in fed WT (red bar) and KO (blue bar) 
POMCS6K1 (E) and AgRPS6K1 (F) mice. Data presented is mean ± SEM.  
(G) Expression of mRNA for type-II iodothyronine deiodinase (Dio2), elongation of very long 
chain fatty acids-3 (Elovl3), peroxisome proliferator-activator receptor-γ coactivator-1α 
(Pgc1a) and uncoupling protein-1 (Ucp1) in brown adipose tissue (BAT) of fasted WT (red 
bar) and KO (blue bar) AgRPS6K1 mutant mice.  N=9-10 mice per genotype. Data 
presented is mean ± SEM.  
(H and I) Expression of mRNA for neuropeptide Y (Npy), pro-opiomelanocortin (Pomc), 
agouti-related peptide (Agrp), carboxypeptidase E (Cpe) and melanocortin-4 receptor (Mc4r) 
in the mediobasal hypothalamus of fasted WT (red bars) and KO (blue bars) POMCS6K1 (H, 
N=18-21 mice per genotype) or AgRPS6K1 (I, N=12 mice per genotype) mice. Data 
presented is mean ± SEM.  
 
 
 
 Figure S3. Leptin sensitivity is not affected by Rps6kb1 deletion 
(A and B) Representative hypothalamic sections showing immunohistochemistry for POMC  
(left) and phosphorylation of STAT3 (pSTAT3) (right) in POMCS6K1 wild-type (WT, A) and 
knockout mice (KO, B) treated with vehicle (top) or i.p. 5 mg/kg leptin (bottom). Scale bar 
represents 100 µm. 
(C) Quantification of co-localization between POMC and pSTAT3 positive neurons. N=3-5 
mice per genotype and treatment. Data presented is mean ± SEM. *P<0.05. 
(D) Immunoprecipitation and western blot analysis for AMPK α1 phosphorylation at S485 
and T172, and for AMPK β1/2 in hypothalamic lysates from WT and nestin-cre S6K1fl/fl (KO) 
mice treated with vehicle or i.p. 5 mg/kg leptin. 
(E and F) Representative current-clamp traces from WT (E) and Rps6kb1-deleted (F) POMC 
neurons in the presence or absence of 50 nM leptin, where indicated. Expanded sections 
underneath are shown before and after the application of leptin.  
(G-I) Representative current-clamp traces from WT (G) and Rps6kb1-deleted (H and I) 
AgRP neurons in the presence or absence of 50 nM insulin, where indicated. Expanded 
sections underneath are before and after the application of insulin.  
(J) Bar charts showing the change in membrane potential (ΔVm) in WT (red bars) and KO 
(blue bars) POMC and AgRP neurons induced by leptin and insulin, respectively. Data is 
presented as mean ± SEM and is inclusive of non-responsive neurons. N=12-16 neurons 
per genotype. *P<0.05 from baseline recordings. No differences were observed between 
genotype.  
(K and L) Representative traces from WT (K) and Rps6kb1-deleted (L) POMC neurons in 
the presence and absence of 5 mM leucine, where indicated.  
 
 
  
 Figure S4. S6K1 in POMC neurons regulates cell body size but combined deletion of 
S6K1 and S6K2 in POMC neurons or deletion of S6K1 in all neurons does not alter 
bodyweight  
(A) Whole-cell capacitance measurements from wild-type (WT, red bar) and knockout (KO, 
blue bar) POMCS6K1-GFP and AgRPS6K1-YFP neurons, N=22-38 neurons per genotype. 
Date presented is mean ± SEM.  
(B) Representative low (left) and high (right) magnification images for POMC immuno-
staining in WT (top) and Rps6kb1-deleted (bottom) POMC neurons. Scale bars represent 
100  and 50 µm for low and high magnification images, respectively. 
(C and D) Quantification of POMC soma diameter (C) and area (D) and calculated at 
equivalent coronal depths between WT and Rps6kb1-deleted cells. N=2471-3563 neurons 
from 4 mice per genotype. Data presented is mean ± SEM. ****P<0.0001. 
(E) Bodyweight of male WT (red bar) and double KO (DKO, blue bar) POMC S6K1/S6K2 
mice at 21 weeks on normal chow or high fat diet (HFD). N=17-24 mice per genotype. Data 
presented is mean ± SEM.  
(F) Daily food intake in male WT (red bar) and DKO (blue bar) POMC S6K1/S6K2 mice on 
normal chow. N=6 mice per genotype. Data presented is mean ± SEM.  
(G) Bodyweight of male WT (red bar) and KO (blue bar) nestin-cre S6K1fl/fl mice at 19 weeks 
on normal chow. N=13 mice per genotype. Data presented is mean ± SEM.  
(H) Insulin-tolerance tests in WT (red circles) and KO (blue circles) male nestin S6K1fl/fl mice 
at 29 weeks of age on normal chow. N=12-13 mice per genotype. Data presented is mean ± 
SEM.  
 
 
 Table S1. CLAMS analysis of metabolism, energy expenditure and locomotion in wild-type (WT) and knockout (KO) POMCS6K1 and 
AgRPS6K1 mutant mice. Related to Figure 2 
POMCS6K1 Male POMCS6K1 Female AgRPS6K1 Male AgRPS6K1 Female  
WT (10) KO (11) WT (10) KO (7) WT (9) KO (6) WT (10) KO (9) 
Light 4.8±0.2 5.5±0.3 4.5±0.5 3.6±0.3 3.3±0.2 3.7±0.1 4.4±0.4 5.0±0.3 VO2 
(ml/g/h) Dark 5.6±0.3 5.6±0.3 5.2±0.6 4.0±0.4 3.9±0.3 4.4±0.2 4.7±0.4 5.2±0.3 
Light 4.8±0.2 5.0±0.3 4.2±0.5 3.2±0.3 3.0±0.2 3.4±0.1 4.1±0.4 4.7±0.3 VCO2 
(ml/g/h) Dark 5.6±0.3 5.6±0.3 5.2±0.6 3.9±0.4 3.9±0.3 4.5±0.2 4.4±0.4 5.2±0.3 
Light 0.71±0.03 0.74±0.04 0.51±0.06 0.40±0.03 0.49±0.04 0.56±0.01 0.54±0.04 0.51±0.02 EE 
(Kcal/h) Dark 0.85±0.05 0.82±0.05 0.60±0.08 0.46±0.04 0.59±0.05 0.68±0.02 0.57±0.05 0.54±0.03 
Light 0.87±0.01 0.91±0.02 0.91±0.02 0.92±0.01 0.90±0.01 0.92±0.01 0.91±0.01 0.92±0.01 RER 
(VCO2/VO2) Dark 0.95±0.02 0.94±0.03 0.99±0.01 0.97±0.02 1.01±0.01 1.02±0.01 0.93±0.01 0.95±0.01 
Light 16.2±2.4 22.6±3.5 21.3±2.8 19.1±2.4 17.6±2.8 12.8±2.6 28.7±3.2 29.8±3.1 x-axis 
(count/min) Dark 55.9±9.6 53.5±11.6 64.1±8.2 56.5±13.6 39.9±5.3 35.3±5.9 44.7±5.0 46.4±5.2 
Light 1.1±0.3 1.2±0.2 2.3±0.7 2.4±0.4 1.2±0.2 1.0±0.2 9.7±3.9 11.4±2.9 z-axis 
(count/min) Dark 6.0±1.2 4.3±1.2 10.3±2.2 10.1±1.4 3.8±0.7 4.2±0.5 13.4±4.2 17.3±3.9 
Data expressed as mean ± SEM during the light and dark phases. Number of mice per genotype shown in parenthesis. EE, energy expenditure; 
RER, respiratory exchange ratio.  
 
 
  
Table S2. Blood glucose and serum insulin concentrations in wild-type (WT) and knockout (KO) POMCS6K1 and AgRPS6K1 mutant mice. 
Related to Figure 2 
POMCS6K1 Male POMCS6K1 Female AgRPS6K1 Male AgRPS6K1 Female  
WT KO WT KO WT KO WT KO 
8 week old, 
Chow 
8.8±0.3 
(24) 
9.0±0.3 
(21) 
8.7±0.3 
(24) 
8.7±0.2 
(24) 
10.5±0.3 
(28) 
10.2±0.3 
(20) 
9.3±0.2 
(29) 
9.6±0.3 
(22) 
26 week old,  
Chow 
9.2±0.3 
(18) 
9.6±0.2 
(22) 
7.9±0.3 
(19) 
8.2±0.3 
(22) 
11.0±0.3 
(33) 
10.3±0.3 
(23) 
10.4±0.4 
(29) 
9.5±0.3 
(25) 
Fed glucose 
(mM) 
26 week old,  
HFD 
11.4±0.5 
(20) 
10.7±0.3 
(21) 
8.5±0.2 
(22) 
8.6±0.2 
(21) 
12.9±0.5 
(26) 
12.7±0.5 
(19) 
9.9±0.3 
(25) 
9.7±0.3 
(15) 
8 week old,  
Chow 
5.3±0.4 
(15) 
4.8±0.2 
(22) 
5.2±0.4 
(17) 
5.8±0.4 
(19) 
6.1±0.1 
(30) 
6.1±0.2 
(23) 
6.0±0.2 
(27) 
6.2±0.2 
(18) 
26 week old,  
Chow 
5.7±0.4 
(18) 
5.6±0.3 
(22) 
6.4±0.3 
(19) 
6.5±0.4 
(22) 
6.4±0.1 
(31) 
6.2±0.2 
(23) 
4.9±0.1 
(31) 
4.9±0.1 
(25) 
Fasted 
glucose (mM) 
26 week old,  
HFD 
7.1±0.4 
(20) 
7.4±0.3 
(21) 
5.6±0.3 
(22) 
5.6±0.3 
(21) 
7.4±0.3 
(25) 
7.6±0.3 
(19) 
7.2 ±0.4 
(24) 
7.3±0.4 
(15) 
Chow 0.53±0.11 
(16) 
0.79±0.17 
(22) 
0.31±0.05 
(16) 
0.38±0.05 
(15) 
0.38±0.03 
(32) 
0.49±0.11 
(21) 
0.58±0.08 
(29) 
0.70±0.23 
(24) 
Fasted insulin 
(ng/ml) 
HFD 0.81±0.15 
(19) 
0.93±0.15 
(21) 
0.50±0.08 
(15) 
0.52±0.14 
(17) 
2.0±0.2 
(26) 
1.7±0.14 
(19) 
0.66±0.11 
(24) 
0.75±0.09 
(13) 
Data expressed as mean ± SEM. Number of mice per genotype shown in parenthesis. HFD, high fat diet 
 SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Genotyping 
For detection of Cre-mediated excision of exons 3 and 4 of Rps6kb1 in the hypothalami of 
AgRPS6K1KO and POMCS6K1KO mice, genomic DNA was isolated from the 
hypothalamus, cortex, liver and skeletal muscle as previously described (Choudhury et al., 
2005). The generation of a ~500 bp DNA product following PCR with primers 
TCCACCCACCAGTAAAGAGC and CCTCAGTCTCCTGAGTGTTAAGG is indicative of the 
floxed allele, whereas deletion is denoted by a ~450 bp band generated by primers 
TCCACCCACCAGTAAAGAGC and ACAAGAGGGCCAGTTGATGG. 
 
Metabolic and food intake studies 
Studies were performed in the animal’s home cage unless indicated. Bodyweights from 
group-housed mice were measured weekly at 9-10am until 26 weeks of age. Glucose (i.p. 2 
g/kg) and insulin (i.p. 0.75 U/kg) -tolerance tests were performed at 8 and 26 weeks of age, 
as previously described (Al-Qassab et al., 2009; Choudhury et al., 2005). At 34 weeks of 
age, fed mice were weighed prior to EchoMRI analysis of body composition. Fasted tail 
blood was analyzed for serum leptin (Millipore) and insulin (Crystal Chem.) by ELISA and for 
FFA (WAKO Chem.) and triglycerides (Sigma Aldrich). Serum corticosterone levels were 
determined by ELISA (Immunodiagnostics Systems) from fed mice. For food intake studies, 
mice were group housed until 10 weeks of age and then singly housed. Mice were allowed 
to acclimatize for 2 weeks and periodically fasted overnight to acclimatize them. Ad-libitum 
food intake was measured over 3 consecutive days and for 24 h following an overnight fast. 
Food intake was measured from singly housed mice injected with either vehicle or leptin (i.p. 
0.3 mg/kg) at 9am and again at 6pm for 3 consecutive days. Food intake was also measured 
in fed mice for 8-24 hours following the injection of ghrelin (i.p. 5 mg/kg) or melanotan-II 
(MTII, i.p. 2 mg/kg) at 9am. Stainless steel cannulae (Plastics One Inc.) were stereotaxically 
implanted into the lateral cerebral ventricle so that the cannula tip was 0.4 mm posterior to 
bregma, 1.0 mm lateral to the midline and -2.1 mm ventral to the surface of the skull. Post-
 surgery, the mice were singly housed, left for one week to recover and then habituated to 
overnight fasts for 2 weeks. Following an overnight fast, mice were injected with 0.5 µl of 
artificial cerebrospinal fluid (aCSF) or leucine (i.c.v. 2.2 µg) and food intake monitored over a 
24 h period. All injections were performed with a 31-gauge stainless steel injector which 
projected 0.5 mm below the tip of the cannula. Following the infusion, the injector was left in 
place for an additional 30 s to allow the drugs to diffuse away from the cannula tip. 
Treatments, with either vehicle or drug, were crossed-over following a 1 week wash-out 
period. Correct cannula placement was confirmed at the end of the study by an increase in 
food intake after i.c.v. administration of NPY (1 µg). Mice were singly housed and habituated 
in CLAMS cages (Columbus Instruments) for 1-2 days prior to assessment of locomotion 
and energy expenditure over the subsequent 2 days.  
 
Automated food intake monitoring 
An episodic food intake monitoring apparatus (BioDAQ, Research Diets, Inc.) was used to 
assess feeding patterns in singly housed mice on normal chow. Food intake was measured 
and averaged from 5 consecutive days to obtain 24 h food intake kinetics. The BioDAQ 
system weighs the hopper with food (± 10 mg) every second and uses an algorithm to 
determine feeding bouts (changes in stable weight before and after a bout). Meals consist of 
one or more bouts separated by an inter-meal interval of 300 s with a minimum meal size of 
20 mg.  
  
Quantitative RT-PCR analysis 
Tissues were lysed and homogenized in TRIzol reagent (Ambion) and total RNA was 
isolated using the RNeasy mini kit (Qiagen). First-strand cDNA was generated using 
Taqman reverse transcription reagents (Applied Biosystems) and qPCR was performed 
using Taqman universal PCR mastermix in a 7900HT real-time PCR system (Applied 
Biosystems). mRNA quantities were normalized to Hprt, Ppia or Gapdh after determination 
by the comparative Ct method. Primers used were: Abcc8 (Mm00803450), Agrp 
 (Mm00475829_g1), Cpe (Mm00516341_m1) Dgat2 (Mm00499536_m1), Dio2 
(Mm00515664_m1), Elov3 (Mm00468164_m1) Fabp4 (Mm00445878_m1), Fasn 
(Mm00662319_m1), Gabra1 (Mm00439046_m1), Gabra2 (Mm00433435_m1), Gabra3 
(Mm01294271_m1), Gabra5 (Mm00621092_m1), Gapdh (Mm99999915_g1), Gck 
(Mm00439129_m1), Hprt (Mm00446968_m1), Lipe (Mm00495359_m1), IL6 (Mm00446190-
m1), Kcnj11 (Mm00440050_m1), Mc4r (Mm00457483_s1), Npy (Mm00445771_m1), Pck1 
(Mm01247058_m1), Pgc1a (Mm00447183_m1), Plin1 (Mm00558672_m1), Pomc 
(Mm00435874_m1), Ppia (Mm03302254_g1), Scd1 (Mm00772290_m1), Ucp1 
(Mm01244861_m1). 
 
Hypothalamic immunohistochemistry 
Immunohistochemistry was performed as previously described (Al-Qassab et al., 2009; 
Choudhury et al., 2005). Fasted mice were injected with leptin (i.p. 5 mg/kg) and perfused 
with paraformaldehyde (4% w/v). Arcuate sections were incubated with rabbit anti-POMC 
precursor (1:1000; Phoenix Pharmaceuticals Inc.) and detection performed using a  
secondary antibody coupled to Alexa-Fluor-488. After extensive washing, slices were 
incubated with a rabbit anti-pSTAT3 (Tyr705) antibody (1.1000, Cell Signaling) which was 
detected using an ABC detection kit (Vector labs). Fluorescent images were taken with an 
epifluorescence microscope fitted with a color digital camera. Mice expressing GFP (POMC-
GFP mouse) or YFP (AgRPCre-YFP) were fixed and arcuate sections incubated with a 
rabbit p70 S6 kinase (49D7, Cell Signaling) primary antibody (1:200) followed by a 
secondary antibody coupled to Alexa-Fluor-594. POMC neuronal measurements were 
counted from labeled cells using ImageJ software.   
 
Electrophysiology 
Hypothalamic coronal slices (350 µm) were cut from aged (3 or 7 month old) matched 
transgenic mice expressing POMCCre/POMC-GFP or AgRPCre/Rosa26YFP with or without 
floxed Rps6bk1. Slices were maintained at room temperature (22-25ºC) in an external 
 solution containing (in mM) NaCl 125, KCl 2.5, NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2 
1, D-glucose 10, D-mannitol 15, equilibrated with 95% O2, 5% CO2, pH 7.4. POMC and 
AgRP neurons were visualized in the arcuate nucleus by the expression and excitation of 
GFP and YFP, respectively. Whole-cell current-clamp (Ifast) recordings were made at ~35°C 
using borosilicate glass pipettes (4-8 MΩ) containing (in mM) Kgluconate 130, KCl 10, EGTA 
0.5, NaCl 1, CaCl2 0.28, MgCl2 3, Na2ATP 3, GTP 0.3, phosphocreatine 14 and HEPES 10 
(pH 7.2), as previously described (Al-Qassab et al., 2009; Choudhury et al., 2005). Following 
a minimum of 10 min of stable recording, hormones were applied for 2-3 min using a broken 
tipped pipette (~3 µm) positioned above the recording neuron. Stock reagents were diluted 
(≥1000 fold) in a modified external solution with NaHCO3 replaced with HEPES (10 mM, pH 
7.4). Stocks of recombinant leptin (R&D Systems) and insulin (Novo-Nordisk Inc.) were 
diluted in HEPES-buffered external solution. All other reagents were purchased from Sigma-
Aldrich. External glucose was replaced with mannitol to maintain osmolarity and biophysical 
properties were obtained from separate recordings in different glucose concentrations. 
Neurons were voltage-clamped at -70 mV using a modified internal solution in which 
Kgluconate was replaced with CsCl (130 mM). Slices were bathed in tetrodotoxin (1 µM) and 
(+)-bicuculline (20 µM) for miniature excitatory currents (mEPSC) or NBQX (5 µM, 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) and AP5 (50 µM (2R)-amino-5-
phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate) for miniature inhibitory 
currents (mIPSC). Note that that there were no statistical differences in the excitable 
properties of POMC neurons in young and old mice (Vm; 3 month, WT: -48.6±1.3 vs KO:  
-53.3±1.6 mV, n=24-29; 7 month, WT: -49.6±2.0 vs KO: -54.1±1.3 mV, n=9-16).  
 
Hyperinsulinemic-euglycemic clamps studies 
Clamps were conducted as previously described (Voshol et al., 2001). Animals were 
anesthetized by intraperitoneal injection of a combination of 6.25 mg/kg acetylpromazine, 
6.25 mg/kg midazolam and 0.31 mg/kg fentanyl. An infusion needle was placed into the tail 
 vein and D-[3H] glucose (specific activity: 10-20Ci (370-740GBq)/mmol) was infused at a rate 
of 0.006 MBq/min for 60 min to achieve steady-state levels. Thereafter, insulin (Actrapid; 
Novo Nordisk) was infused at a constant rate of 0.09 mU/min after a bolus dose of 3.3 mU 
and D-[3H]-glucose was continued at a rate of 0.006 MBq/min. A variable infusion of 12.5% 
D-glucose was used to maintain blood glucose at euglycemic (basal) levels. Blood glucose 
was measured with an AlphaTRAK glucometer (Abbott Animal Health) every 5-10 minutes 
and glucose infusion adjusted accordingly. After 50 minutes from the start of the insulin 
infusion, 14C-2-Deoxy-glucose-phosphate (Specific Activity: 250-350mCi (9.25-
13.0GBq)/mmol) was administered i.v. to assess tissue-specific glucose uptake. Steady-
state was reached after 90 minutes and blood samples were taken at 10 minutes intervals 
over 30 minutes to determine steady-state levels of [3H]-glucose. Mice were then killed by 
cervical dislocation and the organs removed and frozen. Haematocrit was measured at 
baseline and after the clamp (no significant changes were observed between each genotype 
and their littermate controls, data not shown). To measure plasma [3H]-glucose, proteins 
were precipitated with trichloroacetic acid (final concentration 10%), centrifuged, and 
supernatant dried and re-suspended in water. The samples were counted using scintillation 
counting (Hidex Scintilation counter, LabLogic). Tissue samples were homogenized (~5-10% 
wet wt/vol, depending on tissue) in 0.5% percholic acid, centrifuged, supernatants 
neutralized, and 14C-2-Deoxy-glucose-phosphate precipitated using BaOH/ZnSO4. Total and 
precipitated counts of supernatants were subtracted and plasma 14C-2-Deoxy-glucose-
phosphate counts were used to calculate tissue specific uptake. Protein content in 
homogenates was performed using DC protein assay (BioRad). The glucose turnover rate 
(µmol/min) was calculated during the basal period and under steady-state clamp conditions 
as the rate of tracer infusion (dpm/min) divided by the plasma specific activity of [3H] glucose 
(dpm/µmol). The hyperinsulinemic hepatic glucose production was calculated as the 
difference between the tracer-derived rate of glucose appearance and the glucose infusion 
rate.  
 
 Western blot analysis  
Tissues were removed and homogenized in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 
1 mM EDTA, 1% w/v Triton X-100) supplemented with Roche complete protease inhibitor 
cocktail and phosphatase inhibitors (1 mM sodium orthovadanate, 5 mM sodium fluoride and 
2 mM β-glycerophosphate). 20-100 µg of total protein homogenates were run on 15% SDS-
PAGE gels, transferred to PVDF membranes and blotted with antibodies against p70 S6 
Kinase (1:3000, #2708 Cell Signaling), total S6 Ribosomal Protein (1:1000, #2217 Cell 
Signaling), phospo-S6 Ribosomal Protein Ser240/244 (1:1000, #2708 Cell Signaling), and 
tubulin as a loading control (1:10,000, #T5293 Sigma). Detection was performed using 
enhanced chemiluminescence (Luminata Crescento, Millipore) and exposed on films. The 
intensity of the bands was quantified by densitometry using ImageJ software and normalized 
to either β-tubulin or total S6 ribosomal protein. For AMPK studies, hypothalamic tissue was 
homogenized in buffer (50 mM Tris-HCl pH 8.4 (at 4 ͦ C), 50 mM NaF, 5 mM NaPP, 0.25 M 
sucrose (or mannitol), 1 mM EDTA, 1 mM benzamidine, 0.1 mM PMSF, 1 mM DTT) and 
supernatants were either western blotted or used for immunoprecipitation (500 µg). Lysates 
were pre-cleared using protein G sepharose and then immunoprecipitated using a sheep 
antibody specific for AMPK α1. The immune-complexes were washed and run on SDS 
PAGE gels (Novex precast Tris/Bis gels). Antibodies used for blotting AMPKβ1/2, AMPKp-
T172 and AMPKpS485/491 were all from Cell Signaling.  
 
General experimental approaches  
Where possible, investigators were blinded to the genotype of both study animals and that of 
tissue and blood samples. For experiments involving treatments, mice were randomized by 
genotype to study groups or a cross-over design was used where indicated and study 
cohorts were matched for initial bodyweight where appropriate. Treatments were 
administered in random order. All metabolic studies were replicated in at least 2 independent 
cohorts. Study cohort sizes were determined by power calculations based on our previous 
data in mice with targeted hypothalamic mutations. In electrophysiological experiments, a 
 typical mouse allowed 1-5 recordings but observations were repeated on at least 4 different 
mice. 
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